Max Institute of Cancer Care
Decoding GI-HPB Oncology
Gastrointestinal and hepatopancreaticobiliary oncology is a rapidly evolving field that encompasses the diagnosis, work up and treatment of cancers affecting the esophagus, stomach, colon, rectum, appendix, gallbladder, pancreas, liver, and peritoneal surface. These cancers are among the most common and deadly malignancies, and the management of patients with these diseases requires a multidisciplinary approach involving surgeons, medical oncologists, radiation oncologists, and other healthcare professionals.
The recent web series on gastrointestinal and hepatopancreaticobiliary oncology aimed to educate young surgeons and oncologists about the latest developments in the diagnosis and treatment of these diseases. The series covered a wide range of topics, including the epidemiology and risk factors for gastrointestinal and hepatopancreaticobiliary cancers, the pathological features of these tumors, and the various treatment options available.
One of the main focuses of the series was on the surgical management of gastrointestinal and hepatopancreaticobiliary cancers. This included discussions on the principles of surgical resection, the role of neoadjuvant and adjuvant therapy, and the management of postoperative complications. The series also covered the use of endoscopic and radiologic techniques in the diagnosis and staging of these cancers, as well as the role of chemotherapy, targeted therapy, and radiation in the treatment of advanced and metastatic disease.
Overall, the web series on gastrointestinal and hepatopancreaticobiliary oncology provided a comprehensive overview of the current state of the field, and was an invaluable resource for young surgeons and oncologists looking to expand their knowledge and skills in this area.